These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36438823)

  • 21. Constitutive role for IRE1α-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program.
    Ning J; Hong T; Ward A; Pi J; Liu Z; Liu HY; Cao W
    Endocrinology; 2011 Jun; 152(6):2247-55. PubMed ID: 21447637
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
    [No Abstract]   [Full Text] [Related]  

  • 23. (-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.
    Shih CC; Wu JB; Jian JY; Lin CH; Ho HY
    Int J Mol Sci; 2015 Oct; 16(10):24983-5001. PubMed ID: 26492243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
    Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
    Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
    Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
    PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice.
    Zamani-Garmsiri F; Hashemnia SMR; Shabani M; Bagherieh M; Emamgholipour S; Meshkani R
    J Nutr Biochem; 2021 Jan; 87():108505. PubMed ID: 32956824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional interplay between liver X receptor and AMP-activated protein kinase α inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy.
    Ma C; Zhang W; Yang X; Liu Y; Liu L; Feng K; Zhang X; Yang S; Sun L; Yu M; Yang J; Li X; Hu W; Miao RQ; Zhu Y; Li L; Han J; Chen Y; Duan Y
    Br J Pharmacol; 2018 May; 175(9):1486-1503. PubMed ID: 29394501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
    Jin SH; Yang JH; Shin BY; Seo K; Shin SM; Cho IJ; Ki SH
    Toxicol Appl Pharmacol; 2013 Aug; 271(1):95-105. PubMed ID: 23651738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SREBP-2, a new target of metformin?
    Zhang F; Sun W; Chen J; Jiang L; Yang P; Huang Y; Gong A; Liu S; Ma S
    Drug Des Devel Ther; 2018; 12():4163-4170. PubMed ID: 30584280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells.
    Nelson LE; Valentine RJ; Cacicedo JM; Gauthier MS; Ido Y; Ruderman NB
    Am J Physiol Cell Physiol; 2012 Jul; 303(1):C4-C13. PubMed ID: 22378745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver MicroRNA-291b-3p Promotes Hepatic Lipogenesis through Negative Regulation of Adenosine 5'-Monophosphate (AMP)-activated Protein Kinase α1.
    Meng X; Guo J; Fang W; Dou L; Li M; Huang X; Zhou S; Man Y; Tang W; Yu L; Li J
    J Biol Chem; 2016 May; 291(20):10625-34. PubMed ID: 27013659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute exposure to high-fat diets increases hepatic expression of genes related to cell repair and remodeling in female rats.
    Miller CN; Morton HP; Cooney PT; Winters TG; Ramseur KR; Rayalam S; Della-Fera MA; Baile CA; Brown LM
    Nutr Res; 2014 Jan; 34(1):85-93. PubMed ID: 24418250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
    Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
    Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase.
    Quan HY; Kim SJ; Kim DY; Jo HK; Kim GW; Chung SH
    Fitoterapia; 2013 Apr; 86():208-16. PubMed ID: 23500383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of metformin on renal injury of C57BL/6J mouse treated with high fat diet.
    Zhang SQ; Sun YT; Xu TH; Zhang XF; Liu YZ; Ma MJ; Wang LN; Yao L
    Pharmazie; 2014 Dec; 69(12):904-8. PubMed ID: 25951664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
    Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
    Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease.
    Wang Z; Yao T; Song Z
    J Lipid Res; 2010 Nov; 51(11):3158-65. PubMed ID: 20739640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PPARβ/δ Activation prevents hypertriglyceridemia caused by a high fat diet. Involvement of AMPK and PGC-1α-Lipin1-PPARα pathway].
    Barroso E; Astudillo AM; Balsinde J; Vázquez-Carrera M
    Clin Investig Arterioscler; 2013; 25(2):63-73. PubMed ID: 23849213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.